))
Omnipod 5 Real-World Evidence Data: A Deep Dive
Manage episode 435119668 series 3366330
Contenu fourni par Insulet. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Insulet ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Recorded live at the ADA Conference in Orlando, Florida.
Nancy Hanna is joined by Dr. Greg Forlenza who is an Endocrinologist at the University of Colorado School of Medicine – Barbara Davis Center. Dr. Forlenza is the lead author of a publication in the Diabetes Technology & Therapeutics in which the use of the Omnipod 5 Automated Insulin Delivery System was analyzed in almost 70,000 people with type 1 diabetes.
Nancy and Dr. Forlenza discuss the relevance of real-world evidence from a diverse group of patients and how that translates into actual practice. Learn how Omnipod 5 has performed in real-world settings, and why having this data can help personalize diabetes care by understanding how different patient demographics can benefit from tubeless AID technology.
------------
Dr. Greg Forlenza is an endocrinologist. Dr. Forlenza has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.
16 episodes
Partager
